Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania

doi:10.1186/1471-2458-7-338

BMC Public Health
Volume 7

Viewing options:

Abstract
Full text
PDF (240KB)

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Telatela SP
Matee MI
Munubhi EK

on PubMed

Telatela SP
Matee MI
Munubhi EK
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Research article

Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania

Safila P Telatela¹ , Mecky I Matee² and Emmanuel K Munubhi¹

¹Department of Paediatrics and Child Health, Muhimbili University College of Health Sciences, P.O. Box 65001, Dar es Salaam, Tanzania

²Department of Microbiology and Immunology, Muhimbili University College of Health Sciences, P.O. Box 65347, Dar es Salaam, Tanzania

author email corresponding author email

BMC Public Health 2007, 7:338doi:10.1186/1471-2458-7-338


Published:	22 November 2007

Abstract

Background

With increased availability of antibiotics and antifungal agents hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are becoming a cause for significant concern in HIV infected children. We determined the seroprevalence and risk factors for HBV and HCV among HIV infected children aged 18 months to 17 years, attending the Paediatric HIV Care and Treatment Center (CTC) at Muhimbili National Hospital (MNH) in Dar-es-Salaam, Tanzania.

Methods

Investigations included; interviews, physical examination and serology for HBsAg, IgG antibodies to HCV and alanine aminotransferase (ALT) levels. HIV serostatus and CD4 counts were obtained from patient records.

Results

167 HIV infected children, 88(52.7%) males and 79(47.3%) females were enrolled. The overall prevalence of hepatitis co-infection was 15%, with the seroprevalence of HBV and HCV being 1.2% and 13.8%, respectively. Hepatitis virus co-infection was not associated with any of the investigated risk factors and there was no association between HBV and HCV. Elevated ALT was associated with hepatitis viral co-infection but not with ART usage or immune status.

Conclusion

The high seroprevalence (15%) of hepatitis co-infection in HIV infected children attending the Paediatrics HIV CTC at the MNH calls for routine screening of hepatitis viral co-infection and modification in the management of HIV infected children.